ASO Webinar: Obesity and Kidney Disease

Obesity is increasingly becoming a common cause for chronic kidney disease, even in the absence of diabetes or hypertension. In this webinar Dr Neil Docherty, Dr Andrew Frankel and Dr Ricardo Cohen will be discussing the pathophysiology, and medical and surgical treatment options for people with obesity and kidney disease. This will include pharmacotherapy and bariatric surgery to achieve the BMI cut offs for kidney transplantation.

18:00 Opening and introduction - Dr Alex Miras

18:05 Obesity and Chronic Kidney Disease From Association to Causation - Dr Neil Docherty

18:25 Medical treatment of chronic kidney disease associated with obesity with and without diabetes - Dr Andrew Frankel

18:50 Metabolic/Bariatric surgery as a renoprotective intervention - Dr Ricardo Cohen

19:10 Panel Q & A/ discussion

Please join us for the live panel discussion and Q & A session

Novo Nordisk has provided sponsorship to the Association for the Study of Obesity (ASO) to fully fund all costs for the development of this webinar, including creation, organisation, production and administration. Novo Nordisk has had no influence on the content and full editorial control remains the sole responsibility of ASO. None of the speakers have received a fee for their participation in this webinar, and ASO has been fully responsible for engaging with participants.